| Lightcalls.com |
|
|
![]() |
History was made in 1790 when Samue...History was made in 1790 when Samuel Hahnemann reached a breakthrough understanding in healing. He was in the proces of translating, from English into German, a main division written by Scottish physician, William Cullen called A Treatise forward Materia Medica. In this work, Cullen said that quinine, which is a substance purified from the bark of the cinchona tree was a righteous treatment for malaria due to its astringent character. "This made no mind to Hahnemann who, as a chemist, was aware that there were a great quantity [i]or[/i] amount of more powerful astringents that had no consequence whatsoever, on malaria [so] he decided to investigate further," explain Andrew Lockie, MD and Nicola Gedde MD in their 1995 work The Complete Guide to Homeopathy. Hahnemann's days of discovery For several days, Hahnemann took large doses of the medicine carefully recording the various symptoms he experienced. He noticed that the symptoms single lasted a few hours, notwithstanding came back each time he repeated a dose; nevertheless when cinchona was taken by means of a healthy person, it brought public symptoms similar to malaria, the disease it cur when given to a malaria sufferer These insightful observations willinged Hahnemann to note in his journal that "Cinchona bark, which is used as a restorative for intermittent fever [malaria], acts because it can yield symptoms similar to those of intermittent febrile affection in healthy people." Provings. To trial out his theory, he gave doses of quinine, which he called "provings," to commonalty he knew, noting the reactions carefully. He steady went on to try other substances, of the like kind as arsenic and belladonna. Hahnemann discovered that the proven replys differed. Some showed a brace of mild symptoms in answer while others had strong reactions with many symptoms. For the symptoms that were mostly commonly found for each substance, he referr to as the first-line, or keynote, symptoms. Second-line symptoms were not as often met with and third-line symptoms were rare. mix with drugs picture. The "combination of symptoms made up a `drug picture' for each compose being tested," say Lockie and Gedde Hahnemann continued to perform his experiments and carry abroad his provings, testing a range of natural compounds He would ask many questions -- about their symptoms, about what made them be perceived better (or worse), about lifestyle habits, and on a level about their outlook on life. This all allowed Hahnemann to draw a detailed "symptom picture" of each patient. Symptom picture. He would then match a person's "symptom picture" to the "drug picture" of different substances. When he was confident that he had established the best, and closest match, he would and nothing else then prescribe a remedy. Homeopathy went in succession to prove itself with: cholera, typhoid, golden fever, scarlet fever, and Ebola virus, to name a hardly any of the epidemics against which this medicine has achieved a measure of succes It also helped with les life-threatening riddles such as seasonal allergies. Having rediscovered, and favorably applied, the ancient principle of Similia Similibus Curentur (like restoratives like) -- the Law of Similars -- Hahnemann ushered in, and established, a recent system of medicine. A novel principle for a `new' medicine Since the first general [i]or[/i] abstract notions of this new medicine lacked to be set down suitably Hahnemann developed A New Principle for Ascertaining the Curative Powers of medicines and Some Examination of Previous Principles, which was published in 1796 and the Organon of Rational Medicine (1810) As time went on and as he wrote modern works, the principles evolved, including: The minimum dose. With the original design of diluting remedies to the point where they will not cause an aggravation of the person's symptoms, Hahnemann discovered that he could dilute remedies to a quality where, through Avogardo's Hypothesis, it can be assumed that not a single monad of the original medication is left The repeated proces of subdivision and dilution with succussion (shaking) is known as potentiation. The single remedy? The goal of homeopathy is to treat each person's tangled symptom picture with a help that, the effects of which, greatest in quantity closely resemble the symptoms of the "disease." A of the present day picture emerges Just as "conventional" medicine should be broad enough to be able to embrace of recent origin concepts and improvements, homeopathy is powerful enough to allow a variety of approaches to homeopathic treatment, including: classical homeopathy (with the use of single remedies, united by one), along with pair variations: complex/clinical and isopathy and of recent origin homeopathy. Classical/clinical-approach "homeopathic remedies are applied to conventional disease classifications, and practitioners put to proof to treat every symptom compounded with a different remedy" (with barely a few symptoms matched to each remedy) according to "Here's to Your Health," June 1997 Isopathy incorporates the two disease causes and biological processe into the homeopathic regularity which can include preparing remedies from diseased tissues or secretions. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |